25- PPAR ALPHA DELTA WHAT YOU NEED TO KNOW ABOUT THE LATEST RESULTS

Prof Sacks, USA reviews the available data about PPAR alpha delta and the Elafibranor clinical program (RESOVE-IT). The interim results were presented earlier this year. They are somewhat disappointing (especially regarding the primary liver outcome).

0 Comments

Leave a Reply

Your email address will not be published.